Collagen-exosome composite membrane material for uterine cavity repair as well as preparation method and application of collagen-exosome composite membrane material
The collagen-exosome composite membrane material solves the problem of limited repair effect on endometrial damage and intrauterine adhesions, realizes long-term sustained release of exosomes and endometrial regeneration, provides stable physical support and safe degradation products, promotes angiogenesis, and is easy to operate.
Patent Information
- Application Number
- CN202610909347.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-06-23
- Publication Date
- 2026-07-24
AI Technical Summary
Existing treatments for endometrial damage and intrauterine adhesions have limited effectiveness. Mesenchymal stem cell-derived exosomes have short retention times and low local concentrations in the uterine cavity, and thermosensitive collagen exosome hydrogels have unstable morphology and limited in situ maintenance effects.
A collagen-exosome composite membrane material is used. By combining type I collagen with mesenchymal stem cell-derived exosomes to form a porous structure, a stable spatial network structure is constructed using the cross-linking agent 1-ethyl-3-(3-dimethylpropyl)carbodiimide hydrochloride/N-hydroxysuccinimide, thereby achieving long-term sustained release and physical isolation of exosomes.
It significantly prolongs the retention time of exosomes in the uterine cavity, promotes endometrial regeneration and angiogenesis, provides stable physical support, and the degradation products are amino acids or small molecule peptides. It is highly safe and easy to operate.